Tag Archives: Electroencephalography (EEG)

Earlier Diagnosis Research: the Deep and Frequent Phenotyping Study (BBC News / GtR)

Posted on June 28, 2017 by Dementia and Elderly Care News

Summary The Deep and Frequent Phenotyping Study aims to discover new ways of diagnosing dementia, ideally decades before the symptoms become apparent in order to give future drug treatments the best chance of working. The Deep and Frequent Phenotyping Study … Continue reading →

Posted in Alzheimer's Society, BBC News, Commissioning, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Mental Health, Models of Dementia Care, National, NIHR, Quick Insights, UK, Universal Interest | Tagged Ageing Population, Alterations in Movement and Walking (“Gait”) Assessments, Alzheimer's Disease: Early Detection by Brain Scan, Alzheimer’s Disease Biomarkers, Amnestic Mild Cognitive Impairment (a-MCI), Amnestic Mild Cognitive Impairment (aMCI), Applications of Big Data, BBC Radio, BBC Radio 4, BBC's World At One Programme, Big Data Analytics, Big Data Funding and Research, Biomarker Assessments in Alzheimer’s Disease, Biomarker Assessments in Alzheimer’s Disease Clinical Trials, Biomarker Assessments in Clinical Trials, Biomarker Development, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, Biomarkers Research Programmes, Blood and Urine Biomarkers, Blood-Based Biomarkers, Blood-Based Biomarkers of Pre-Symptomatic Alzheimer’s Disease, Brain Scans, Cambridge Neuropsychological Test Automated Battery (CANTAB), Cerebrospinal Fluid (CSF) Biomarkers, Clinical Assessments, Cognitive Assessments / Screening Tools, Conversion to Dementia From Prodromal Disease, CSF Biomarkers, Deep and Frequent Phenotyping Study, Deep and Frequent Phenotyping Study (DFP), Deep and Frequent Phenotyping; Combinatorial Biomarkers of Dementia, Dementia Research, Dementia Research Funding, Dementias Platform UK, Dementias Platform UK (DPUK), Dementias Platform UK: MRC, DFP Study Team, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, DPUK: Dementias Platform UK, Drug Trials Failure Rate, Early Detection of Alzheimer’s Disease, Early Detection of Preclinical Disease, EEG: Electroencephalography, Effectiveness of Early Detection and Treatment, Electroencephalogram (EEG) Brain Scans, Electroencephalography (EEG), Gait and Cognition, Gait Changes, Gateway to Research (GtR), Global Dementia Research, Global Leadership, Hypothetical Prodromes of Dementia, Imanova, Imperial College London, Join Dementia Research, Join Dementia Research: Clinical Trials Matchmaker Service, Join Dementia Research: Recruitment Onto Dementia Studies, Kings College London, Magnetic Resonance Imaging (MRI) Scan, Magnetoencephalography (MEG), Medical Research Council (MRC), Medical Research Council (UK), National Institute of Health Research (NIHR), Neurobiology of Aging (Journal), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, Newcastle University, Non-Invasive Biomarkers, Ocular Manifestations in Neurodegenerative Diseases, Open Data and Big Data, Ophthalmological Assessments, Participation in Research, Participation in Research Studies, Partnership and Collaboration, Patient and Public Participation, PharmaCog Consortium, Positron Emission Tomography (PET), Pre-Clinical Genotype-Phenotype Predictors of Alzheimer's Disease, Prodromal Alzheimer's Disease, Professor Clare Mackay: Imaging Neuroscience at the University of Oxford, Professor Lynn Rochester: Clinical Ageing Research Unit at Newcastle University, Professor Simon Lovestone: Lead Researcher and Professor of Translational Neuroscience at University of Oxford, Protein-Based Biomarkers in Blood May Deliver Accurate Diagnoses, Proteomic Analysis, Proteomics, Public Participation in Research, Publicly-Funded UK Big Data Research, Research and Development, Research and Innovation, Research Commitment, Research Culture, Research Funding, Retina as Early Biomarker of Neurodegeneration, Retinal Biomarkers, Retinal Changes as Surrogate Biomarker for Alzheimer's Disease, Retinal Ganglion Cells (RGCs), Retinal Manifestations of Alzheimer's Disease, Screening Tools for Amnestic Mild Cognitive Impairment (a-MCI), Surrogate Biomarkers of Neurodegeneration, Translational Research, University College London, University of Cambridge, University of Edinburgh, University of Manchester, University of Oxford, Volunteers, Walking Pattern (Gait), Wearable Devices, Wearables (Technology) | Leave a comment

Deep and Frequent Phenotyping Study: Dementia Early Detection and Biomarkers Research Programme (MRC / NIHR)

Posted on August 22, 2016 by Dementia and Elderly Care News

Summary The Deep and Frequent Phenotyping Study will explore improvements in biomarker research and the development of tests to detect Alzheimer’s Disease early on. This research programme will be funded by the National Institute of Health Research (NIHR) and the … Continue reading →

Posted in Alzheimer's Society, Charitable Bodies, Commissioning, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, National, NIHR, Quick Insights, UK, Universal Interest | Tagged Alterations in Movement and Walking (“Gait”) Assessments, Alzheimer's Disease: Early Detection by Brain Scan, Alzheimer’s Disease Biomarkers, Aridhia, AstraZeneca / MedImmune, Berry Consultants, Biomarker Assessments in Alzheimer’s Disease, Biomarker Assessments in Alzheimer’s Disease Clinical Trials, Biomarker Assessments in Clinical Trials, Biomarker Development, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, Biomarkers Research Programmes, Blood and Urine Biomarkers, Blood-Based Biomarkers, Blood-Based Biomarkers of Pre-Symptomatic Alzheimer’s Disease, Brain Scans, Cambridge Cognition, Cerebrospinal Fluid (CSF) Biomarkers, Clinical Assessments, Cognitive Assessments / Screening Tools, Conversion to Dementia From Prodromal Disease, CSF Biomarkers, Deep and Frequent Phenotyping Study, Dementia Research, Dementia Research Funding, Dementias Platform UK, Dementias Platform UK (DPUK), Dementias Platform UK: MRC, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, DPUK: Dementias Platform UK, Dr Rob Buckle: Director of Science Programmes at MRC, Drug Trials Failure Rate, Early Detection of Alzheimer’s Disease, Early Detection of Preclinical Disease, EEG: Electroencephalography, Effectiveness of Early Detection and Treatment, Electroencephalogram (EEG) Brain Scans, Electroencephalography (EEG), Exprodo, Gait and Cognition, Gait Changes, Global Dementia Research, Global Leadership, Hypothetical Prodromes of Dementia, Imanova, Imperial College London, IXICO, Kings College London, Magnetic Resonance Imaging (MRI) Scan, Magnetoencephalography (MEG), Medical Research Council (MRC), Medical Research Council (UK), National Institute of Health Research (NIHR), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, Newcastle University, Non-Invasive Biomarkers, Ocular Manifestations in Neurodegenerative Diseases, Ophthalmological Assessments, Optos, Participation in Research, Participation in Research Studies, Partnership and Collaboration, Patient and Public Participation, Positron Emission Tomography (PET), Pre-Clinical Genotype-Phenotype Predictors of Alzheimer's Disease, Prodromal Alzheimer's Disease, Professor Chris Whitty: Chief Scientific Adviser at Department of Health, Professor Simon Lovestone: Lead Researcher and Professor of Translational Neuroscience at University of Oxford, Protein-Based Biomarkers in Blood May Deliver Accurate Diagnoses, Proteomic Analysis, Proteomics, Public Participation in Research, Research and Development, Research and Innovation, Research Commitment, Research Culture, Research Funding, Retina as Early Biomarker of Neurodegeneration, Retinal Biomarkers, Retinal Changes as Surrogate Biomarker for Alzheimer's Disease, Retinal Ganglion Cells (RGCs), Retinal Manifestations of Alzheimer's Disease, Sage Bionetworks, Surrogate Biomarkers of Neurodegeneration, Translational Research, TrialSpark, University College London, University of Cambridge, University of Edinburgh, University of Manchester, University of Oxford, Volunteers, Walking Pattern (Gait), Wearable Devices, Wearables (Technology), West London Mental Health Trust / Imperial College London | 1 Comment

More on the Association Between Dementia and Poor Sleep Quality (NHS Choices / Nature Neuroscience)

Posted on June 29, 2015 by Dementia and Elderly Care News

Summary Recent US research found an apparent link between poor sleep quality and higher levels abnormal protein (beta-amyloid plaques) in the brain. The following NHS Choices Behind the Headlines critical appraisal puts the limitations of this interesting research into perspective. … Continue reading →

Posted in For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Quick Insights, Universal Interest | Tagged Amyloid Beta, Amyloid Beta Protein, Amyloid Proteins, Amyloid-β (Aβ), Amyloid-β (Aβ) Accumulation, Amyloid-β Protein, ß-amyloid, Behind the Headlines, Beta-Amyloid Plaques, Beta-Amyloid Protein in Medial Prefrontal Cortex (Reduced NREM Sleep), Better Sleep Hub (NHS Choices), California Pacific Medical Center, California Pacific Medical Center (San Francisco), Cognitive Decline, Critical Appraisals, Department of Psychiatry: University of California, Diminished NREM SWA, Electroencephalography (EEG), Functional Magnetic Resonance Imaging (fMRI), Helen Wills Neuroscience Institute: University of California, Hippocampus-Dependent Cognitive Decline, Hippocampus-Dependent Memory Consolidation, Impaired NREM Slow Wave Activity (SWA), β-Amyloid Disruption of NREM Slow Waves, β-Amyloid Pathology and Memory Impairment, Lawrence Berkeley National Laboratory, Lawrence Berkeley National Laboratory (Berkeley California), Medial Prefrontal Cortex (mPFC), Nature Neuroscience, Need For Sleep, NHS Choices Sleep Hub, Non-Rapid Eye Movement (NREM) Sleep, NREM Slow Wave Activity (SWA), NREM SWA, Poor Sleep Quality, Positron Emission Tomography (PET), Sleep, Sleep and Dementia, Sleep and Neuroimaging Laboratory: University of California, Sleep Deprivation, Sleep Disturbance, Sleep Duration, Sleep Hygiene, Sleep Quality, Sleeping Well, United States, University of California, US National Institutes of Health, US National Institutes of Health (NIH), USA | Leave a comment

Glasgow Coma Scale Update (Nursing Times / BBC News / PLoS Computational Biology / Nature Communications)

Posted on October 16, 2014 by Dementia and Elderly Care News

Summary The Glasgow Coma Scale has been updated forty years after its initial implementation. This Nursing Times article reviews the variations in technique which have developed since then, the scale’s current composition and application and the “structured approach” to the … Continue reading →

Posted in BBC News, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Quick Insights, Scotland, UK, Universal Interest | Tagged Assessment of Impaired Consciousness, BBC Health News, Brain and Mind Institute: University of Western Ontario, Brain Imaging, Brain Networks in Disorders of Consciousness, Cambridge Biomedical Campus, Cambridge University Hospitals NHS Foundation Trust, Cognition and Brain Sciences Unit (MRC), Connectivity and Graph-Theoretic Analysis, Department of Clinical Neurosciences: University of Cambridge, Disorders of Consciousness, Electroencephalography (EEG), Electrooculographic (EOG) Activity, Glasgow Caledonian University, Glasgow Coma Scale, Glasgow Coma Scale (GCS), Glasgow Coma Scale Update, IGMM: University of Edinburgh, Impaired Consciousness, Institute of Health and Wellbeing: University of Glasgow, Institute of Neurological Sciences Glasgow, Institute of Neurological Sciences: Southern General Hospital (Glasgow)), Laboratory of Cognitive and Social Neuroscience: Universidad Diego Portales, Magnetic Resonance Imaging (MRI), Medical Research Council: Cognition and Brain Sciences Unit, Nature Communications, Neuroimaging, Neuroimaging Tools, NHS Lothian, Nursing Times, Patient's Awareness Networks (Consciousness Levels), Persistent Vegetative State, PLoS Computational Biology, Reduced Consciousness, Relating Coma Scale to Coma Score, Southern General Hospital (Glasgow)), Spectral Power, Swiss Institute of Technology, Tennis Test, Universidad Diego Portales (Chile), University of California, University of California at Los Angeles, University of Cambridge, University of Edinburgh, University of Glasgow, University of Western Ontario, Vegetative State | Leave a comment

Appropriate Use of Neuroimaging in Dementia Diagnosis (Ontario Health Technology Assessment Series / BBC News)

Posted on April 4, 2014 by Dementia and Elderly Care News

Summary This economic literature review and cost-effectiveness analysis investigated neuroimaging for diagnostic purposes, and in particular examined whether computed tomography (CT) or magnetic resonance imaging (MRI) should be used. It was not possible to answer the specific research questions with … Continue reading →

Posted in BBC News, Diagnosis, For Doctors (mostly), For Researchers (mostly), In the News, International, Systematic Reviews | Tagged BBC Health News, Benign Primary Brain Tumour, Brain Imaging, Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCC), Centre for Imaging Science: Hammersmith Hospital, CT Brain Imaging, CT Versus MRI, Diagnostic Imaging, Electroencephalography (EEG), Imaging, Imaging Services, Magnetic Resonance Imaging (MRI), Malignant Primary Brain Tumour, Meningiomas, MRI, MRI Scans, Neuro-Technology Patents, Neuroimaging, Neuroimaging in Dementia Diagnosis, Neuroimaging of Dementia, Neuroimaging Tools, NINCDS-ADRDA: National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer Disease and Related Disorders Association, Ontario Health Technology Assessment Series, Positron Emission Tomography (PET), SharpBrains, Single-Photon Emission Computed Tomography (SPECT or Less Commonly SPET), Subdural Hematoma (SDH), THETA: Toronto Health Economics and Technology Assessment | Leave a comment

EFNS-ENS Guidelines on Diagnosis and Management of Disorders Associated with Dementia (European Federation of Neurological Societies)

Posted on September 1, 2012 by Dementia and Elderly Care News

[A version of this item appears in: Dementia and Elderly Care: the Latest Evidence Newsletter (RWHT), Volume 3 Issue 3, October 2012]. Summary The revised EFNS guidelines for Alzheimer’s Disease (AD) were published in 2010. The new EFNS dementia guidelines … Continue reading →

Posted in Acute Hospitals, Community Care, For Doctors (mostly), For Researchers (mostly), Guidelines, International, Patient Care Pathway, Quick Insights, Standards, Systematic Reviews, Universal Interest | Tagged Behavioral and Psychological Symptoms of Dementia (BPSD), Blood Tests, BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, Carer Support, Cerebrospinal Fluid (CSF), Corticobasal Syndrome, Counselling, CSF, Dementia Guidelines (EFNS), Dementia with Lewy Bodies, Department of Neurological and Psychiatric Sciences: University of Florence, Diagnosis, Disclosure of Diagnosis, DLB: Dementia with Lewy Bodies, EEG: Electroencephalography, EFNS, EFNS Dementia Guidelines, EFNS-ENS Guidelines, Electroencephalography (EEG), European Federation of Neurological Societies (EFNS), European Journal of Neurology, Frontotemporal Dementia, Frontotemporal Lobar Degeneration, Genetic Tests, Huntington’s Disease, Legal Issues, Limbic Encephalitis, Mixed and Vascular Dementia, Neuroimaging, Neuropsychology, Normal-Pressure Hydrocephalus, Parkinson’s Disease Dementia, Pick’s Disease (Frontotemporal Dementia), Prion Diseases, Progressive Supranuclear Palsy, Supporting Caregivers, Toxic and Metabolic Disorders, University of Florence, Vascular Cognitive Impairment, Vascular Dementia | Leave a comment

TMS-EEG Response Characteristics (Future Directions in the Diagnosis and Assessment of Dementia?)

Posted on June 11, 2011 by Dementia and Elderly Care News

Abstract The authors of this article suggest that the combination of transcranial magnetic stimulation (TMS) and electroencephalography (EEG) may be used to identify distinct differences in Alzheimer’s Disease and MCI patients. They found that the TMS-EEG response P30 amplitude correlates … Continue reading →

Posted in Diagnosis, For Researchers (mostly), International | Tagged Diagnosis and Assessment, EEG: Electroencephalography, Electroencephalography (EEG), TMS-EEG Response Characteristics, TMS: Transcranial Magnetic Stimulation, Transcranial Magnetic Stimulation (TMS) | 1 Comment

Tag Archives: Electroencephalography (EEG)

Earlier Diagnosis Research: the Deep and Frequent Phenotyping Study (BBC News / GtR)

Deep and Frequent Phenotyping Study: Dementia Early Detection and Biomarkers Research Programme (MRC / NIHR)

More on the Association Between Dementia and Poor Sleep Quality (NHS Choices / Nature Neuroscience)

EFNS-ENS Guidelines on Diagnosis and Management of Disorders Associated with Dementia (European Federation of Neurological Societies)

TMS-EEG Response Characteristics (Future Directions in the Diagnosis and Assessment of Dementia?)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites